Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Use Surveillance of ADCETRIS + AVD in Untreated CD30-Positive Hodgkin Lymphoma
jRCT1080224121Completed
- Sponsor
- Takeda
- Start
- Oct 2018
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of brentuximab vedotin in Hodgkin lymphoma (HL), sponsored by Takeda. Started Oct 2018; status: completed.
02
Drugs
brentuximab vedotin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on jRCT1080224121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224121.